SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-080473
Filing Date
2023-03-27
Accepted
2023-03-27 16:18:00
Documents
15
Period of Report
2023-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d490495d8k.htm   iXBRL 8-K 30153
2 EX-10.1 d490495dex101.htm EX-10.1 9260
3 EX-99.1 d490495dex991.htm EX-99.1 9396
7 GRAPHIC g490495g56a31.jpg GRAPHIC 3375
  Complete submission text file 0001193125-23-080473.txt   182752

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20230321.xsd EX-101.SCH 2866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20230321_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20230321_pre.xml EX-101.PRE 10823
9 EXTRACTED XBRL INSTANCE DOCUMENT d490495d8k_htm.xml XML 3261
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 23764744
SIC: 2834 Pharmaceutical Preparations